Clinical trial
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients…
NCT00413322 · Valerio Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00413322 |
|---|---|
| Title | Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors |
| Official title | A Phase I Safety, Pharmacodynamic, Anti-Tumor Activity, and Pharmacokinetic Study of PXD101 Alone and in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors |
| Lead sponsor | Valerio Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumor |
| Intervention type | Drug |
| Interventions | belinostat, 5-Fluorouracil (5-FU) |
| Enrollment | 35 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Dec 19, 2006 |
| Last update posted | Jul 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: